ClinicalTrials.gg
Sign In

Renal Insufficiency clinical trials

The registry lists 1,409 studies for Renal Insufficiency across more than 10 countries. 143 are recruiting or about to start. 726 of them are mainly about Renal Insufficiency (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-10. Counting its 4 narrower conditions too, such as Renal Insufficiency, Chronic: 7,549 studies, 1,389 open.

ClinicalTrials.gov finds 7,871 studies for Renal Insufficiency. How that becomes 1,408 here

This page counts the studies the registry files under Renal Insufficiency, and those it files under no condition that list Renal Insufficiencythemselves. Each study its search finds is placed by how the registry filed it and by the conditions it lists. ClinicalTrials.gov counts as of Nov 8, 2026. How condition pages count

  1. 7,871Found by its condition searchIt reads the conditions a study lists and their synonyms, and also titles and keywords.
  2. −6,009Filed under a narrower condition, counted on its own pageRenal Insufficiency, Chronic 2,920 · Kidney Failure, Chronic 1,559 · Acute Kidney Injury 1,436 · Cardio-Renal Syndrome 48
  3. −50List Renal Insufficiency as a condition, but the registry did not file them under itMost often written as “End Stage Renal Failure on Dialysis” (22), “Renal Failure Chronic Requiring Hemodialysis” (13), and “Renal Failure Chronic Requiring Dialysis” (3). The registry filed them under other conditions only, most often Inflammation (5) and Kidney Diseases (5).
  4. −426Match it another way117 name it in the title, 6 in a keyword, and 303 by a synonym or other text the search reads.
  5. 1,386Counted here and found by its search12 of them list Renal Insufficiency in their own words; the registry filed them under no condition.
  6. +22
    Counted here, but its search does not find themThe first 20 of 22.
  7. 1,408The count on this page

Get an email when these change. Save the Renal Insufficiency studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
921
Status unknown
132
Terminated
120
Recruiting
90
Not yet recruiting
49
Withdrawn
48

Phase

Phase 1
413
Phase 2
153
Phase 3
150
Phase 4
136
Early Phase 1
8

Where

United States
552
Germany
139
France
107
Canada
79
United Kingdom
60
China
59

Who runs them

Novartis Pharmaceuticals (30) · Pfizer (25) · AstraZeneca (23) · Merck Sharp & Dohme LLC (22) · Massachusetts General Hospital (15) · Fresenius Medical Care Deutschland GmbH (15) · GlaxoSmithKline (14) · Astellas Pharma Inc (13)

What is being tested here

Drugs under test in Renal Insufficiency studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Cyclophosphamide3110
Dexamethasone218
Isatuximab203
Dapagliflozin138
Rituximab106
Empagliflozin115
Furosemide115
Bortezomib105
Terlipressin113
Dexmedetomidine103

Drug classes tested here Tyrosine kinase inhibitors (TKIs) 3 open · SGLT2 inhibitors 3 open · Alkylating agents 3 open · Diuretics 2 open · Corticosteroids 2 open

Coming up

8phase 3 studies under way
61studies finish main data collection within a year2 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 90 Renal Insufficiency studies recruiting now, 47 (52%) set no upper age limit and 18 (20%) stop at 75 or younger. 8 (9%) take children under 18. 3 (3%) are for women only and 1 (1%) for men only; 15 (17%) take healthy volunteers.

Recruiting studies that take each age, of 90
AgeWomenMen
105 (6%)6 (7%)
1877 (86%)75 (83%)
3083 (92%)80 (89%)
4086 (96%)83 (92%)
5085 (94%)83 (92%)
6585 (94%)83 (92%)
7575 (83%)74 (82%)
8560 (67%)59 (66%)

Across all 1,409 studies, recruiting or not: 26% stop at 75 or younger and 9% at 65; 9% take children; 1% are for women only and 1% for men only; 27% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Renal Insufficiency studies take

Of 230 phase 1 interventional studies under Renal Insufficiency, half reached primary completion within 8 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 18 mo5–16 · 230 studies8 mo5–15 · 212 studies—
Phase 230 mo13–34 · 26 studies——
Phase 342 mo24–77 · 36 studies——
Phase 437 mo20–48 · 32 studies—38 mo20–67 · 29 studies
Interventional, no phase22 mo8–48 · 149 studies16 mo4–27 · 31 studies22 mo8–49 · 118 studies
Observational30 mo14–56 · 101 studies—29 mo14–58 · 86 studies

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Started recruiting5

Results posted3

Stopped2

Newly registered6

Show 1 more

Studies

Recruiting first, then most recently updated. Showing 50 of 1,409. Browse all 1,409 → or search them.